<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Relmada Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Relmada Therapeutics, Inc.

    We are a clinical stage, publicly traded specialty pharmaceutical company, focused on developing dextromethadone (REL-1017) as a rapid-acting oral treatment for depression, CNS and ophthalmological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Sergio Traversa, PharmD, MBA
    • FOUNDED
      2004
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    MiMedx Group, Inc.

    MiMedx Group, Inc.

    MiMedxŽ is a biopharmaceutical company developing, manufacturing and marketing reg...

    MiMedxŽ is a biopharmaceutical company developi...

    Filing Type:    PU
    AdaptHealth Corp.

    AdaptHealth Corp.

    We are a network of full-service medical equipment companies that use tailored pro...

    We are a network of full-service medical equipm...

    Filing Type:    PU
    Progenics Pharmaceuticals Inc.

    Progenics Pharmaceuticals Inc.

    Progenics develops innovative medicines and other technologies to target and treat...

    Progenics develops innovative medicines and oth...

    Filing Type:    PU
    Gilead Sciences, Inc.

    Gilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers...

    Gilead Sciences, Inc. is a research-based bioph...

    Filing Type:    PU
    CTI BioPharma Corp.

    CTI BioPharma Corp.

    CTI BioPharma is a biopharmaceutical company focused on the acquisition, developme...

    CTI BioPharma is a biopharmaceutical company fo...

    Filing Type:    PU
    Sage Therapeutics, Inc.

    Sage Therapeutics, Inc.

    Sage Therapeutics is a biopharmaceutical company committed to developing novel the...

    Sage Therapeutics is a biopharmaceutical compan...

    Filing Type:    PU
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company...

    VistaGen Therapeutics (NASDAQ: VTGN) is a clini...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.